SEGMENT REPORTING (Tables)

9 Months Ended

Sep. 30, 2020

Segment Reporting [Abstract]

SCHEDULE OF SEGMENT INFORMATION

The CODM allocates resources to and assesses the performance of each segment using information about its revenue and operating income (loss). These measures are presented in the following tables (in thousands). Asset information by segment is not presented, as this measure is not used by the CODM to assess the segment’s performance.

	For the Three Months Ended						For the Nine Months Ended
	September 30,						September 30,
	2020			2019			2020			2019
Net revenues by segment:
Regenerative medicine	$	1,156		$	839		$	2,528		$	1,640
Contract services		2,181			556			4,008			2,546
Total net revenues	$	3,337		$	1,395		$	6,536		$	4,186
Net income (loss) by segment:
Regenerative medicine	$	(7,246	)	$	(22,466	)	$	(32,516	)	$	(70,247	)
Contract services		165			(517	)		(282	)		(1,101	)
Total net loss	$	(7,081	)	$	(22,983	)	$	(32,798	)	$	(71,348	)